# England’s NHS to Offer Eli Lilly Obesity Drug to Some Patients ### Key Points: – The National Health Service (NHS) in England will provide the option of a new obesity drug, developed by Eli Lilly, to selected patients. – This decision is part of a broader effort to tackle the growing obesity crisis in the country. – The drug, called tirzepatide, showed promising results in clinical trials by assisting patients in losing weight. – By offering this pharmaceutical option, the NHS aims to provide additional support to individuals struggling with obesity. The National Health Service’s initiative to introduce the Eli Lilly obesity drug is a proactive step towards addressing the challenges posed by obesity. This decision reflects a commitment to exploring diverse solutions to support individuals in their weight loss journeys. For more information on how Mindful Evolution can assist you in achieving your weight loss goals through telehealth services, please visit our website at https://yourmindfulevolution.com or reach out to us via call or text at 954-639-9960. ***Weight Loss Disclaimer: Individual results may vary. Mindful Evolution provides telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia.***